Surgery Partners receives ‘buy’ rating — 4 facts

Eight research firms rated Nashville, Tenn.-based Surgery Partners shares a “buy,” according to Community Financial News.

Advertisement

Here are four facts:

1. Analysts have a $21 12-month price objective on Surgery Partners’ shares.

2. On Oct. 12, 2016, Zacks lowered Surgery Partners’ shares from a “hold” to a “sell” rating.

3. On Nov. 10, 2016, Jeffries Group restated its “buy” rating on the company’s shares.

4. Surgery Partners has a market cap. of $682.54 million.

More articles on surgery centers:
Maintaining infection control compliance at ASCs: 4 key strategies to yield success
Parkview Medical Center unveils multimillion-dollar expansion plans featuring surgery center: 4 points
Hennepin County Medical Center slashes workforce by 4% to boost budget for $200M ASC — 4 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.